West Pharmaceutical Services vs Insulet vs DexCom Revenue Comparison
Compare financial metrics side-by-side using real SEC EDGAR data
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: West Pharmaceutical Services 0.872, Insulet 0.762, DexCom 1.192.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, West Pharmaceutical Services, Insulet, DexCom.| Metric | West Pharmaceutical Services | Insulet | DexCom |
|---|---|---|---|
| Market Cap | $23.90B | $11.48B | $28.76B |
| Revenue | $872.00M | $762.00M | $1.19B |
| Cost of Revenue | $543.00M | $233.00M | $442.00M |
| Gross Profit | $329.00M | $529.00M | $750.00M |
| Operating Income | $179.00M | $122.00M | $255.00M |
| Net Income | $154.00M | $91.00M | $200.00M |
| R&D Expense | $20.00M | $90.00M | $145.00M |
| Earnings Per Share | $2.15 | $1.3 | $0.51 |
| Gross Margin | 37.7% | 69.5% | 63.0% |
| Operating Margin | 20.5% | 16.0% | 21.4% |
| Net Profit Margin | 17.6% | 12.0% | 16.7% |
| Free Cash Flow | $81.00M | $86.00M | $449.00M |
| Cumulative Free Cash Flow | $3.60B | $-97.00M | $3.21B |
| Operating Cash Flow | $124.00M | $114.00M | $526.00M |
| Cash & Equivalents | $436.00M | $480.00M | $1.12B |